NUCB2 and gestational diabetes: The overall pooled analysis indicated that no evident differences existed between GDM cases and healthy controls in regard to circulating nesfatin-1 levels (SMD = − 0.11, 95% CI, − 0.61–0.38, P = 0.65; Fig. 2c).